Evaluating the Safety and Immune Response to a Dengue Virus Vaccine in Healthy Adults

NCT01931176 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

14

Enrollment

NIH

Sponsor class

Conditions

Dengue

Interventions

BIOLOGICAL: rDEN2Δ30-7169 vaccine
BIOLOGICAL: Placebo

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)